- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT05447468
Influence of Proximal Motor Control in Treating Lateral Epicondylitis
1. juli 2022 oppdatert av: Shereen Mohamed, Cairo University
This study will be conducted to investigate the effect of scapular muscles (lower trapezius, middle trapezius and serratus anterior) strengthening on pain, pain free hand grip strength and functional outcome added to conventional physical therapy in patients with chronic Lateral Epicondylitis.
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Detaljert beskrivelse
This study will try to investigate if scapular muscles strengthening have an effective role on pain, pain free hand grip strength and function when added to conventional physical therapy in patients with LE.
Studietype
Intervensjonell
Registrering (Forventet)
52
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Shereen Mohamed, physiotherapist
- Telefonnummer: +201153470826
- E-post: shereenm34@gmail.com
Studiesteder
-
-
-
Dokki, Egypt, 34518
- Outpatient clinic, Faculty of Physical Therapy, Cairo university
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
30 år til 50 år (Voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Symptoms of lateral epicondylitis from at least the past 3 months.
- Pain in at least two of the following four tests; Tomsen test, Maudsley test, Mill's test and handgrip dynamometer test.
- Their ages range from 30-50 years old.
Exclusion Criteria:
Subjects will be excluded from the study if they have:
- Peripheral neuropathy.
- Lesions of upper limb nerves.
- History of surgery in the affected elbow 6 months ago.
- Cervical radiculopathy.
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: scapular muscles strengthning group
Patients in this group A will receive scapular muscles (lower trapezius, middle trapezius and serratus anterior) strengthening along with conventional physiotherapy (pulsed ultrasound, static stretching of ECRB muscle and eccentric exercises of wrist extensors) for 6 weeks.
|
Ask the patient to raise arm above the head with upper extremity in line with lower trapezius muscle fibers in prone position with the shoulder joint at 135 degrees.
The patient will be asked to hold position 6 seconds and perform 3 sets of 10 repetitions and 3times per week for 6 weeks.
Shoulder external rotation with the shoulder abducted 90ₒ and elbow flexed 90ₒ in prone position with elbow supported on the table.
The patient will be asked to hold position 6 seconds and perform 3 sets of 10 repetitions and 3times per week for 6 weeks.
Ask the patient to raise the arm on a wall in the plane of the scapula in standing position. The patient will be asked to hold position 6 seconds and perform 3 sets of 10 repetitions and 3times per week for 6 weeks.
With a 20% duty cycle, frequency of 1 MHz and intensity of 1.5 w/cm² for 5 minutes 3 times per week for 6 weeks.
Put the elbow in extension, forearm in pronation and wrist in flexion with ulnar deviation.
Hold for 30s and repeat 3 times with 30s rest in between.
Three times per week for 6 weeks.
Ask the patient to extend elbow, pronate forearm, extend wrist and then flex the wrist slowly until full flexion is achieved.
Patients should apply 3 sets of 10 repetitions 3 times per week for 6 weeks.
|
Aktiv komparator: conventional physiotherapy group
Patients in this group B will receive conventional physiotherapy only (pulsed ultrasound, static stretching of ECRB muscle and eccentric exercises of wrist extensors) 3 sessions per week for 6 weeks.
|
With a 20% duty cycle, frequency of 1 MHz and intensity of 1.5 w/cm² for 5 minutes 3 times per week for 6 weeks.
Put the elbow in extension, forearm in pronation and wrist in flexion with ulnar deviation.
Hold for 30s and repeat 3 times with 30s rest in between.
Three times per week for 6 weeks.
Ask the patient to extend elbow, pronate forearm, extend wrist and then flex the wrist slowly until full flexion is achieved.
Patients should apply 3 sets of 10 repetitions 3 times per week for 6 weeks.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Assessment of change in pain intensity
Tidsramme: at baseline and after 6 weeks of intervention
|
Using Visual analouge scale (VAS), a continuous 10 cm line ranges from no pain to very severe pain which is valid and reliable tool.
The patient marks on the line the point that they feel represents their pain intensity.
|
at baseline and after 6 weeks of intervention
|
Assessment of change in hand grip strength
Tidsramme: at baseline and after 6 weeks of intervention
|
Patient stands with the elbow in complete extension and the shoulder and radioulnar joints in neutral rotation.
Ask the patient to slowly squeeze the dynamometer and to stop the instant discomfort is first felt.
It will be performed three repetitions separated by a 20-second rest interval.
Average of three trials will be recorded.
The measurement is valid and reliable.
|
at baseline and after 6 weeks of intervention
|
Assessment of change in function
Tidsramme: at baseline and after 6 weeks of intervention
|
Using PRTEEQ.
It is a 15-item self-reported questionnaire to measure perceived pain and disability in people with LE.
It has three subscales: pain, usual activities and specific activities.
Each of the items of the Patient rated tennis elbow evaluation questionnaire (PRTEEQ) is scored on a 0-10 scale, where 0 is 'no pain' or 'no difficulty' and10 is 'worst ever' or 'unable to do.
Ask the patients to rate the pain and difficulty that they have experienced in the last week by marking the suitable response that reflects their current state.
The total score ranges from 0 to 100, where high scores indicate greater pain and disability.
|
at baseline and after 6 weeks of intervention
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Shereen Mohamed, physiotherapist, shereenm34@gmail.com
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Forventet)
15. juli 2022
Primær fullføring (Forventet)
15. oktober 2022
Studiet fullført (Forventet)
1. november 2022
Datoer for studieregistrering
Først innsendt
1. juli 2022
Først innsendt som oppfylte QC-kriteriene
1. juli 2022
Først lagt ut (Faktiske)
7. juli 2022
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
7. juli 2022
Siste oppdatering sendt inn som oppfylte QC-kriteriene
1. juli 2022
Sist bekreftet
1. juli 2022
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- P.T.REC/012/003304
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
UBESLUTTE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Lateral epikondylitt
-
Mayo ClinicThe Patient Company, LLCRekrutteringLateral pasientoverføringForente stater
-
Arthrex, Inc.Aktiv, ikke rekrutterendeLateral ankelinstabilitetForente stater
-
Hospital for Special Surgery, New YorkAktiv, ikke rekrutterendeLateral epikondylitt | Lateral epikondylitt, uspesifisert albue | Lateral epikondylitt, venstre albue | Lateral epikondylitt, høyre albue | Lateral epikondylitt (tennisalbue) Bilateral | Medial epikondylitt | Medial epikondylitt, høyre albue | Medial epikondylitt, venstre albueForente stater
-
Ahmed ZewailFullførtTannimplantat | Lateral sinusløftingEgypt
-
University of OklahomaFullførtLateral Window Sinus AugmentationForente stater
-
Saint-Joseph UniversityFullførtLateral sinusløft | Komplikasjoner per operasjonLibanon
-
Eirion Therapeutics Inc.Aktiv, ikke rekrutterendeKråkeføtter | Lateral Canthal Lines, LCLForente stater
-
Eirion Therapeutics Inc.FullførtKråkeføtter | Lateral Canthal Lines, LCLForente stater
-
AllerganFullførtCrow's Feet Lines | Lateral Canthus RhytidesBelgia, Canada, Forente stater, Storbritannia
-
AllerganFullført
Kliniske studier på Strength of lower trapezius
-
Sheba Medical CenterHebrew University of JerusalemFullførtType 2 diabetes | Aldring | Kognitiv nedgangIsrael
-
Winthrop UniversityRekruttering
-
Adenocyte, LLCHar ikke rekruttert ennåBukspyttkjertelkreft | Abdominal neoplasma | Gulsott
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell UniversityAvsluttetEndetarmskreft | for tarmdysfunksjon etter kirurgi for endetarmskreftForente stater